Vaxil Bio is a cutting-edge Israeli biotech focused on immuno-oncology as innovative cancer treatments. Vaxil's lead product, Immucin, has recently been granted "Orphan Drug Status"​ from both the FDA and the EMA agencies. Vaxil is based out of the Weizmann Science Park, Israel's top scientific i... Read more